This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Molecure S.a.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kamil Lisiecki - Innovator in Therapeutic Applications
Introduction
Kamil Lisiecki is an inventor based in Pultusk, Poland. He is currently associated with Molecure S.A., where he focuses on developing innovative therapeutic solutions. Although he has not yet been granted any patents, his work is significant in the field of medical research.
Latest Patent Applications
Kamil Lisiecki's notable patent application is titled "YKL-40 Inhibitors and Their Therapeutic Applications." This invention pertains to novel inhibitors of chitinase-like protein YKL-40 and their therapeutic applications. These YKL-40 inhibitors are designed to serve as therapeutic agents for the treatment of various diseases and disorders, including cancers, inflammation, and pulmonary diseases.
Conclusion
Kamil Lisiecki is making strides in the field of therapeutic innovations, particularly through his work on YKL-40 inhibitors. His contributions have the potential to impact the treatment of significant health issues.